You can buy or sell ALX Oncology and other stocks, options, and ETFs commission-free!
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.
52 Week High
52 Week Low
— per share